The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
T helper cells that produce interleukin 17 (IL-17) are associated with inflammation and the control of certain bacteria. We report here the essential involvement of the adaptor protein Act1 in IL-17 receptor (IL-17R) signaling and IL-17-dependent immune responses. After stimulation with IL-17, recruitment of Act1 to IL-17R required the IL-17R conserved cytoplasmic 'SEFIR' domain, followed by recruitment of the kinase TAK1 and E3 ubiquitin ligase TRAF6, which mediate 'downstream' activation of transcription factor NF-kappaB. IL-17-induced expression of inflammation-related genes was abolished in Act1-deficient primary astroglial and gut epithelial cells. This reduction was associated with much less inflammatory disease in vivo in both autoimmune encephalomyelitis and dextran sodium sulfate-induced colitis. Our data show that Act1 is essential in IL-17-dependent signaling in autoimmune and inflammatory disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The initial event in IL-17R signaling is recruitment of Act1 (aka CIKS), a multifunctional signaling protein that also contains a SEFIR domain necessary for IL-17R-Act1 association”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Qian et al., 2007
In the citing paper
“upon IL-17 signaling, Act1 rapidly recruits and ubiquitinates TNF-receptor associated factor (TRAF)6”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Qian et al., 2007
In the citing paper
“Act1 is best understood as a nonredundant activator of IL-17RA-dependent signals”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Qian et al., 2007
In the citing paper
“TRAF6 also promotes activation of MAPK/AP1 pathways and the C/EBPβ and δ transcription factors”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Qian et al., 2007
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Interleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372
Ye, P., Rodriguez, F. H., Kanaly, S., Stocking, K. L., Schurr, J., Schwarzenberger, P., Oliver, P., Huang, W., Zhang, P., Zhang, J., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.519 · Cited by 1,521 · cited 1×
“Because IL-17 has a critical function in neutrophilia through the upregulation of chemokines, which is important for the development of inflammatory diseases including coliti”
BackgroundDong, Y., & Benveniste, E. N. (2001) · Glia · doi:10.1002/glia.1107 · Cited by 1,293 · cited 1×
“Because astrocytes are responsive to IL-17 and are important in the production of cytokines and chemokines during EA”
BackgroundTRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
Lomaga, M. A., Yeh, W.-C., Sarosi, I., Duncan, G. S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.1015 · Cited by 1,267
Research works printed but not linked: 13
- Mangan, P.R. et al. Transforming growth factor-β induces development of the TH17 lineage. Nature 441, 231–234 (2006). · DOI · Paper page
- Kolls, J.K. & Linden, A. Interleukin-17 family members and inflammation. Immunity 21, 467–476 (2004). · DOI · Paper page
- Novatchkova, M., Leibbrandt, A., Werzowa, J., Neubuser, A. & Eisenhaber, F. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem. Sci. 28, 226–229 (2003). · DOI · Paper page
- Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005). · DOI · Paper page
- Iwakura, Y. & Ishigame, H. The IL-23/IL-17 axis in inflammation. J. Clin. Invest. 116, 1218–1222 (2006). · DOI · Paper page
- Kolls, J.K. & Linden, A. Interleukin-17 family members and inflammation. Immunity 21, 467–476 (2004). · DOI · Paper page
- Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005). · DOI · Paper page
- Weaver, A. et al. An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization. FASEB J. 19, 1668–1670 (2005). · DOI · Paper page
- Becher, B., Bechmann, I. & Greter, M. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J. Mol. Med. 84, 532–543 (2006). · DOI · Paper page
- Gold, R., Linington, C. & Lassmann, H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129, 1953–1971 (2006). · DOI · Paper page
- Koenders, M.I. et al. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. Arthritis Rheum. 52, 3239–3247 (2005). · DOI · Paper page
- Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005). · DOI · Paper page
- Han, Y., Wang, J., Zhou, Z. & Ransohoff, R.M. TGFβ1 selectively up-regulates CCR1 expression in primary murine astrocytes. Glia 30, 1–10 (2000). · DOI · Paper page
Cited by
Items 201–300 of 623
Bertoletti, A., Tan, A. T., & Bert, N. L. (2021) · Oxford Open Immunology · doi:10.1093/oxfimm/iqab006 · Cited by 74
Huang, S. U.-S., & O’Sullivan, K. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073793 · Cited by 80
IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation
Floudas, A., Saunders, S. P., Moran, T., Schwartz, C., Hams, E., Fitzgerald, D. C., Johnston, J. A., Ogg, G. S., McKenzie, A. N., Walsh, P. T., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602185 · Cited by 69
IL-17A–Induced PLET1 Expression Contributes to Tissue Repair and Colon Tumorigenesis
Zepp, J. A., Zhao, J., Liu, C., Bulek, K., Wu, L., Chen, X., Hao, Y., Wang, Z., Wang, X., Ouyang, W., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601540 · Cited by 70
“Act1- and Act1-deficient (both C57BL/6) mice were generated as described (13).”
MethodSelf-citationPhosphorylation-dependent Regnase-1 release from endoplasmic reticulum is critical in IL-17 response
Tanaka, H., Arima, Y., Kamimura, D., Tanaka, Y., Takahashi, N., Uehata, T., Maeda, K., Satoh, T., Murakami, M., & Akira, S. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20181078 · Cited by 79
Tan, X.-X., Qiu, L.-L., & Sun, J. (2021) · BioMed Research International · doi:10.1155/2021/3883204 · Cited by 74
“And in the development of multiple sclerosis and cerebral hemorrhage, some research had suggested that IL-17 was involved in the inflammatory response [39, 40].”
BackgroundHigh prevalence of increased interleukin-17A serum levels in postmenopausal estrogen deficiency
Molnár, I., Bohaty, I., & Somogyiné-Vári, É. (2014) · Menopause · doi:10.1097/gme.0000000000000125 · Cited by 66
“The Act1-dependent IL-17 receptor signaling pathway leads to the expression of inflammation-related genes in autoimmune and inflammatory diseases.(6) IL-17 is a new candidate in the pathogenesis of osteoporosis-stimulating cytokine secretion for osteoclastogenesis.”
BackgroundFujiu, K., & Nagai, R. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0357-x · Cited by 75
“Among them, the post-transcriptional modification of IL-17 can stabilize the mRNA of many cytokines through AU-rich elements in the 30UTR, a common feature of inflammatory cytokine genes [80].”
BackgroundCOVID-19 causes neuronal degeneration and reduces neurogenesis in human hippocampus
Bayat, A., Azimi, H., Moghaddam, M. H., Ebrahimi, V., Fathi, M., Vakili, K. G., Mahmoudiasl, G., Forouzesh, M., Boroujeni, M. E., Nariman, Z., et al. (2022) · APOPTOSIS · doi:10.1007/s10495-022-01754-9 · Cited by 74
“Linking IL-17 to its receptors can lead to the generation of pro-inflammatory cytokines and uptake the nuclear factor κB (NFκB) activator 1 (Act1) [74].”
BackgroundMoncunill, G., Aponte, J. J., Nhabomba, A. J., & Dobaño, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052587 · Cited by 67
Sharma, A. K., Mulloy, D. P., Le, L. T., & Laubach, V. E. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00205.2013 · Cited by 67
Mancini, F., Monaci, E., Lofano, G., Torre, A., Bacconi, M., Tavarini, S., Sammicheli, C., Arcidiacono, L., Galletti, B., Laera, D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147767 · Cited by 71
“TNF could also be important since it can not only synergize with IL-17A and IL-17F, which on their own are poor activators of signaling [44, 45], but also prime neutrophils, rendering them faster and more efficient against pathogens [46, 47].”
BackgroundSaran, A., Nishizaki, D., Lippman, S. M., Kato, S., & Kurzrock, R. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.01.002 · Cited by 71
Huang, S. U.-S., & O’Sullivan, K. M. (2022) · doi:10.20944/preprints202203.0021.v1 · Cited by 65
Protective role of macrophage-derived ceruloplasmin in inflammatory bowel disease
Bakhautdin, B., Febbraio, M., Goksoy, E., de la Motte, C. A., Gulen, M. F., Childers, E. P., Hazen, S. L., Li, X., & Fox, P. L. (2012) · Gut · doi:10.1136/gutjnl-2011-300694 · Cited by 69
“Scoring of histopathology and colonic bleeding was done by an individual blinded to the treatment.(18) Immunohistochemistry Formalin-fixed, paraffin-embedded colon sections were deparaffinised in xylene and rehydrated with alcohol.”
MethodSelf-citationTAOK1 negatively regulates IL-17-mediated signaling and inflammation
Zhang, Z., Tang, Z., Ma, X., Sun, K., Fan, L., Fang, J., Pan, J., Wang, X., An, H., & Zhou, J. (2018) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.158 · Cited by 66
Mechanism by which TRAF6 Participates in the Immune Regulation of Autoimmune Diseases and Cancer
Wang, J., Wu, X., Jiang, M., & Tai, G. (2020) · BioMed Research International · doi:10.1155/2020/4607197 · Cited by 67
“Th17 cytokines, particularly IL-17, induce the upregulation of RANKL and osteoclast differentiation mediated by the Act1/TRAF6/NFκB and AP-1 pathways [83].”
BackgroundImmune regulation of bone loss by T h17 cells in oestrogen‐deficient osteoporosis
Zhao, R. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12158 · Cited by 66
Tian, X., Wei, W., Cao, Y., Ao, T., Huang, F., Javed, R., Wang, X., Fan, J., Zhang, Y., Liu, Y., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17086 · Cited by 64
Targeting IL-17 in autoimmunity and inflammation
Kim, B. S., Park, Y.-J., & Chung, Y. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0823-8 · Cited by 66
Feng, Y., Chen, Z., Tu, S.-Q., Wei, J.-M., Hou, Y., Kuang, Z., Kang, X.-N., & Ai, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.862415 · Cited by 71
“Act1 binds to IL-17RA and IL-17RC through the SEFIR domain of them (33), and then recruits TRAF6 (34).”
BackgroundAn in‐depth analysis of the immunomodulatory mechanisms of intervertebral disc degeneration
Song, C., Cai, W., Liu, F., Cheng, K., Guo, D., & Liu, Z. (2022) · JOR Spine · doi:10.1002/jsp2.1233 · Cited by 63
“NF-B activator 1 (ACT1), which starts the NF-B pathway, has a SEFIR domain and a TRAF6 binding motif.(65) When IL-17A binds to IL-17R (IL-17RA/IL-17RC), Act1 binds to IL-17A receptor through”
BackgroundAhmad, R., Sylvester, J., & Zafarullah, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.08.013 · Cited by 67
Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases
Nirula, A., Nilsen, J., Klekotka, P. A., Kricorian, G., Erondu, N., Towne, J. E., Russell, C. B., Martin, D. A., & Budelsky, A. (2016) · Rheumatology · doi:10.1093/rheumatology/kew346 · Cited by 63
Characterization of Lamprey IL-17 Family Members and Their Receptors
Han, Q., Das, S., Hirano, M., Holland, S. J., McCurley, N., Guo, P., Rosenberg, C. S., Boehm, T., & Cooper, M. D. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500892 · Cited by 60
“This domain is also found in Act1, which serves an important role in IL-17R– mediated signaling (57); Act1 is recruited to IL-17R through SEFIR–SEFIR interaction (58) and, in turn, recruits and ubiquitinates TRAF6 to mediate downstream activation of NF-kB (33, 59).”
BackgroundCytokine control of inflammation and repair in the pathology of multiple sclerosis.
Rodgers, J. M., & Miller, S. D. (2012) · PubMed Central · Cited by 70
Xia, W., Bai, J., Wu, X., Wei, Y. Z., Feng, S., Li, L., Zhang, J., Xiong, G., Fan, Y., Shi, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098915 · Cited by 60
“Recently, a novel signaling molecule, act1, was found to be a key component in IL-17A signaling [30].”
BackgroundGenetics of susceptibility and treatment response in psoriatic arthritis
O’Rielly, D. D., & Rahman, P. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.169 · Cited by 63
“TRAF3 interacting protein 2 (TRAF3IP2) is essential for T H 17-cell-mediated inflammatory responses”
BackgroundThe biological and clinical importance of the 'new generation' cytokines in rheumatic diseases
Gabay, C., & McInnes, I. B. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2680 · Cited by 71
“Act1, which encodes an apparent SEFIR domain, is essential for IL-17R downstream signalling through mutual SEFIRdependent interactions to activate NF-κB and TAK1 [96].”
BackgroundSEF/IL-17R (SEFIR) Is Not Enough
Onishi, R. M., Park, S. J., Hanel, W., Ho, A. W., Maitra, A., & Gaffen, S. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121418 · Cited by 56
The pleiotropic role of interleukin-17 in atherosclerosis
Allam, G. A., Abdel‐Moneim, A., & Gaber, A. M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.110 · Cited by 60
The Double Game Played by Th17 Cells in Infection: Host Defense and Immunopathology
Paroli, M., Caccavale, R., Fiorillo, M. T., Spadea, L., Gumina, S., Candela, V., & Paroli, M. P. (2022) · Pathogens · doi:10.3390/pathogens11121547 · Cited by 62
Neuroinflammation of traumatic brain injury: Roles of extracellular vesicles
Liu, X., Zhang, L., Cao, Y., Jia, H., Li, X., Li, F., Zhang, S., & Zhang, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1088827 · Cited by 67
Self-citationValente, A. J., Clark, R. A., Siddesha, J. M., Siebenlist, U. K., & Chandrasekar, B. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.04.009 · Cited by 56
“CIKS plays major roles in various immune and inflammatory diseases, particularly those involving T helper type-17 lymphocytes that express interleukin-17 [36, 37].”
BackgroundUndenatured type II collagen and its role in improving osteoarthritis
Xu, R., Wu, J., Zheng, L. P., & Zhao, M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102080 · Cited by 61
Ge, D., Dauchy, R. T., Liu, S., Zhang, Q., Mao, L., Dauchy, E. M., Blask, D. E., Hill, S. M., Rowan, B. G., Brainard, G. C., et al. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12084 · Cited by 58
“IL-17 (including IL-17A, IL-17F, and IL-17A/F) binds to a heterodimer of IL-17RA/ IL-17RC receptor complex, leading to recruitment of nuclear factor-κB (NF-κB) activator 1(Act1) through SEFIR (similar expression to fibroblast growth factor genes, IL-17 receptors and Toll–IL-1R) domains that exist in IL-17RA, IL-17RC,…”
BackgroundSelf-citationLiu, C., Swaidani, S., Qian, W., Kang, Z., Sun, P., Han, Y., Wang, C., Gulen, M. F., Yin, W., Zhang, C., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001843 · Cited by 54
“For reconstitution assays in MEFs, cells were infected by retroviral supernatant as described previously (23).”
BackgroundMethodSelf-citationShibabaw, T., Teferi, B., & Ayelign, B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1094823 · Cited by 57
“In turn, IKKa then phosphorylates the IkB subunit of the NF-kB/IkB complex, marking IkB for E3 ubiquitin ligase–proteasomal proteolysis (42, 43).”
BackgroundCytokine mediators of Th17 function
Spolski, R. J., & Leonard, W. J. (2009) · European Journal of Immunology · doi:10.1002/eji.200839066 · Cited by 62
Ciccacci, C., Biancone, L., Fusco, D. D., Ranieri, M., Condino, G., Giardina, E., Onali, S., Lepre, T., Pallone, F., Novelli, G., et al. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.02.020 · Cited by 56
The Interleukin 17 System in Cortical Lesions in Focal Cortical Dysplasias
He, J., Li, S., Shu, H., Yu, S., Liu, S., Yin, Q., & Yang, H. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318281262e · Cited by 56
Shi, P., Zhu, S., Lin, Y., Liu, Y., Liu, Y., Chen, Z., Shi, Y., & Qian, Y. (2011) · Science Signaling · doi:10.1126/scisignal.2001653 · Cited by 50
“Studies have begun to unveil the mechanisms of IL-17R signaling (6, 27, 30, 31, 34, 35, 48).”
BackgroundSelf-citationProfiles of microRNA networks in intestinal epithelial cells in a mouse model of colitis
Lee, J., Park, E. J., Yuki, Y., Ahmad, S., Mizuguchi, K., Ishii, K. J., Shimaoka, M., & Kiyono, H. (2015) · Scientific Reports · doi:10.1038/srep18174 · Cited by 52
IL-17 and IL-21: Their Immunobiology and Therapeutic Potentials
Koh, C., Kim, B., Kang, C., Chung, Y., & Seo, H. (2024) · Immune Network · doi:10.4110/in.2024.24.e2 · Cited by 56
“24.e2 3/24 https://immunenetwork.org domain, which is crucial for its association with IL-17R (20,21).”
BackgroundTsukimoto, M., Nakatsukasa, H., Sugawara, K., Yamashita, K., & Kojima, S. (2008) · Radiation Research · doi:10.1667/rr1352.1 · Cited by 52
Garaud, J. C., Schickel, J., Blaison, G., Knapp, A., Dembélé, D., Ruer‐Laventie, J., Korganow, A., Martin, T., Soulas-Sprauel, P., & Pasquali, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023900 · Cited by 56
“Among these genes, it is interesting to note that TRAF3IP2 (alias ACT1) is a negative regulator of B cell function, its absence leading to lymphoproliferation and autoantibody production [20], but ACT1 is also essential in IL-17 dependent signaling during autoimmune diseases [21], IL-17 being implicated during lupus p…”
BackgroundPaunović, V., Carroll, H. P., Vandenbroeck, K., & Gadina, M. (2008) · Rheumatology · doi:10.1093/rheumatology/kem352 · Cited by 58
Chenuet, P., Fauconnier, L., Madouri, F., Marchiol, T., Rouxel, N., Ledru, A., Mauny, P., Lory, R., Uttenhove, C., Snick, J. V., et al. (2017) · Clinical Science · doi:10.1042/cs20171034 · Cited by 52
Notch1 Signaling Regulates the Th17/Treg Immune Imbalance in Patients with Psoriasis Vulgaris
Ma, L., Xue, H., Gao, T., Gao, M., & Zhang, Y. (2018) · Mediators of Inflammation · doi:10.1155/2018/3069521 · Cited by 51
“Act1 is a key adaptor molecule in IL-17 signaling and plays a very important role in IL-17 signal transduction [34].”
BackgroundEpithelial TRAF6 drives IL-17–mediated psoriatic inflammation
Matsumoto, R., Dainichi, T., Tsuchiya, S., Nomura, T., Kitoh, A., Hayden, M. S., Ishii, K. J., Tanaka, M., Honda, T., Egawa, G., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.121175 · Cited by 51
“TRAF6 is required for the IL-17R signaling pathway in mouse embryonic fibroblasts (37).”
BackgroundZhao, Y., Cooper, D. K. C., Wang, H., Chen, P., He, C., Cai, Z., Mou, L., Luan, S., & Gao, H. (2019) · Xenotransplantation · doi:10.1111/xen.12502 · Cited by 52
Interleukin-17: Potential Target for Chronic Wounds
Hadian, Y., Bagood, M. D., Dahle, S. E., Sood, A., & Isseroff, R. R. (2019) · Mediators of Inflammation · doi:10.1155/2019/1297675 · Cited by 55
Chen, J., He, R.-R., Sun, W., Gao, R., Peng, Q., Zhu, L., Du, Y., Ma, X., Guo, X., Zhang, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15564-7 · Cited by 54
Self-citationLiu, C., Zhen, D., Du, H., Gong, G.-H., Wu, Y., Ma, Q., & Quan, Z. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115343 · Cited by 53
Self-citationAlunno, A., Carubbi, F., Bartoloni, E., Bistoni, O., Caterbi, S., Cipriani, P., Giacomelli, R., & Gerli, R. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.08.022 · Cited by 51
“in the presence of the tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6) [20].”
BackgroundComprehending the complex connection between PKCβ, TAK1, and IKK in BCR signaling
Shinohara, H., & Kurosaki, T. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00836.x · Cited by 56
“heat shock protein 90 (Hsp90) for IL-1b signaling (147), Act1 for IL-17 signaling (86), MUC1 for constitutive NF-jB signaling (148), and JIP1 and BS69 for JNK-specific activation in viral protein signaling (75, 149).”
BackgroundNDR1 protein kinase promotes IL‐17‐ and TNF‐α‐mediated inflammation by competitively binding TRAF3
Ma, C., Lin, W., Liu, Z., Tang, W., Gautam, R., Li, H., Qian, Y., Huang, H., & Wang, X. (2017) · EMBO Reports · doi:10.15252/embr.201642140 · Cited by 53
“Taken together, NDR1 positively regulates the pathogenesis of IBD and EAE in vivo by the promotion of IL-17-mediated signaling rather than the induction of IL-17 cells.”
InfluentialSelf-citationYang, Y., Liu, Y.-J., Tang, S., Yang, L., Yang, J., Cao, G., Zhang, J., Wang, X., & Mao, Y.-Z. (2013) · Pediatric Surgery International · doi:10.1007/s00383-013-3421-6 · Cited by 51
“Th17 cells exert their function mainly by secreting IL- 17a which has pleiotropic effects, including induction of pro-inflammatory cytokines such as IL-23, IL-6, IL-8 and IL-1 as well as chemokines such as CXCL (CXC-chemokine ligand)-1 (GRO-a), CXCL2, CXCL3, CXCL6(GCP-2), CXCL8(IL-8), CCL2(MCP-1) and CCL (CC-chemokine…”
BackgroundSuyama, K., Sakai, D., & Watanabe, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.857164 · Cited by 52
Act1 is a negative regulator in T and B cells via direct inhibition of STAT3
Zhang, C.-J., Wang, C., Jiang, M., Gu, C., Xiao, J., Chen, X., Martin, B. N., Tang, F., Yamamoto, E. A., Xian, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04974-3 · Cited by 55
Self-citationRoles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions
Yi, Z., Lin, W., Stunz, L. L., & Bishop, G. A. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.12.002 · Cited by 52
New insights into the function of Interleukin-25 in disease pathogenesis
Yuan, Q., Peng, N., Xiao, F., Shi, X., Zhu, B., Rui, K., Tian, J., & Lu, L. (2023) · Biomarker Research · doi:10.1186/s40364-023-00474-9 · Cited by 54
IL-17 in osteoarthritis: A narrative review
Xiao, J., Zhang, P., Cai, F.-L., Luo, C., Pu, T., Pan, X.-L., & Tian, M. (2023) · Open Life Sciences · doi:10.1515/biol-2022-0747 · Cited by 61
Self-citationRole of Interleukin- (IL-) 17 in the Pathogenesis and Targeted Therapies in Spondyloarthropathies
Chyuan, I., & Chen, J.-Y. (2018) · Mediators of Inflammation · doi:10.1155/2018/2403935 · Cited by 54
“Act1, a critical intermediate adaptor between IL-17RA and TRAF6, is recruited after IL-17A stimulation and binds to IL-17RA through SEFIR-dependent interactions [18].”
BackgroundFrom Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment
Vidal, S., Puig, L., Carrascosa, J. M., González‐Cantero, Á., Ruiz‐Carrascosa, J., & Velasco-Pastor, A.-M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136740 · Cited by 48
“Moreover, despite the crucial role of ACT-1, some ACT1-independent signaling in response to IL-17Rs activation has also been described [82,83].”
BackgroundWolf, K., Plano, G. V., & Fields, K. A. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01290.x · Cited by 53
“…signalling pathway leading to NFkB activation Although Act1 has been implicated in numerous signal transduction pathways, evidence indicates that Act1 is essential and plays a direct role in IL-17-dependent activation of proinflammatory gene transcription in epithelial cells (Qian et al., 2007).”
BackgroundInfluentialHu, L., Edamatsu, H., Takenaka, N., Ikuta, S., & Kataoka, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901816 · Cited by 49
The IL-17A/IL-17RA axis in pulmonary defence and immunopathology
Lorè, N. I., Bragonzi, A., & Cigana, C. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.03.009 · Cited by 52
FGF2 cooperates with IL-17 to promote autoimmune inflammation
Shao, X., Chen, S., Yang, D., Cao, M., Yao, Y., Wu, Z., Li, N., Shen, N., Li, X., Song, X., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07597-8 · Cited by 46
Self-citationNeddylation-Independent Activities of MLN4924
Mao, H., & Sun, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1025-0_21 · Cited by 45
T Cell-Derived Act1 Is Necessary for IL-25–Mediated Th2 Responses and Allergic Airway Inflammation
Swaidani, S., Bulek, K., Kang, Z., Gulen, M. F., Liu, C., Yin, W., Abbadi, A., Aronica, M. A., & Li, X. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002790 · Cited by 50
“These mice were further bred onto Act1 floxed mice (Traf3ip2) (21) to generate the control mice (Lck-CreTraf3ip2) and T cell-specific Act1-deficient mice (Lck-CreTraf3ip2).”
BackgroundSelf-citationAssociation of IL-17A and IL-17 F gene polymorphisms with recurrent pregnancy loss in Iranian women
Najafi, S., Hadinedoushan, H., Eslami, G., & Aflatoonian, A. (2014) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-014-0294-0 · Cited by 46
“Binding IL-17 to its receptor initiates signalling pathways which induce the production of proinflammatory cytokines and chemokines and induce the recruitment of neutrophils [9, 10].”
BackgroundInterleukin-17A activation on bronchial epithelium and basophils: a novel inflammatory mechanism
Wong, C. K., Cao, J., Yin, Y.-B., & Lam, C. W. K. (2009) · European Respiratory Journal · doi:10.1183/09031936.00088309 · Cited by 44
Neurodegenerative Diseases: Unraveling the Heterogeneity of Astrocytes
Santiago-Balmaseda, A., Aguirre-Orozco, A., Valenzuela-Arzeta, I. E., Villegas-Rojas, M. M., Pérez‐Segura, I., Jiménez-Barrios, N., Hurtado-Robles, E., Rodríguez-Hernández, L. D., Rivera-German, E. R., Guerra‐Crespo, M., et al. (2024) · Cells · doi:10.3390/cells13110921 · Cited by 49
CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunction
Venkatesan, B. A., Valente, A. J., Das, N. A., Carpenter, A. J., Yoshida, T., Delafontaine, J.-L., Siebenlist, U. K., & Chandrasekar, B. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.10.009 · Cited by 43
Porphyromonas gingivalis: a potential trigger of neurodegenerative disease
Huang, Z., Hao, M., Shi, N., Wang, X., Lin, Y., Yuan, H., & Wang, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1482033 · Cited by 53
Chen, C., Zhang, Q., Liu, S., Parajuli, K. R., Qu, Y., Mei, J., Chen, Z., Zhang, H., Khismatullin, D. B., & You, Z. (2015) · The Prostate · doi:10.1002/pros.22971 · Cited by 42
“When it binds to a heterodimer of IL-17RA/IL-17RC receptor complex, IL-17 is able to activate nuclear factor-kB (NF-kB) activator 1 (Act1) through SEFIR (similar expression to fibroblast growth factor genes, IL-17 receptors, and Toll-IL-1R) domains [11–15].”
BackgroundSelf-citationIκBζ is a key player in the antipsoriatic effects of secukinumab
Bertelsen, T., Ljungberg, C., Litman, T., Huppertz, C., Hennze, R., Rønholt, K., Iversen, L., & Johansen, C. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.09.029 · Cited by 46
IL‐17 and anti‐bacterial immunity: Protection versus tissue damage
Cooper, A. M. (2009) · European Journal of Immunology · doi:10.1002/eji.200839090 · Cited by 45
The inflammatory Th 17 subset in immunity against self and non-self antigens
Jin, D., Zhang, L., Zheng, J., & Zhao, Y. L. (2008) · Autoimmunity · doi:10.1080/08916930701776605 · Cited by 48
“[81] Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF, Jane-Wit D, Xiao J, Lu Y, Giltiay N, Liu J, Kordula T, Zhang QW, Vallance B, Swaidani S, Aronica M, Tuohy VK, Hamilton T, Li X.”
BackgroundIL-17 Signaling-Independent Central Nervous System Autoimmunity Is Negatively Regulated by TGF-β
González-García, I., Zhao, Y., Ju, S., Gu, Q., Liu, L., Kolls, J. K., & Lu, B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802221 · Cited by 42
“In addition, Act1, a molecule within the IL-17 signal transduction pathway is required for EAE (18, 19).”
BackgroundResistin-Like Molecule α Decreases Glucose Tolerance during Intestinal Inflammation
Munitz, A., Seidu, L., Cole, E. T., Ahrens, R., Hogan, S. P., & Rothenberg, M. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803130 · Cited by 41
“Of note, Relm- was found to significantly regulate colonic expression of IL-17, a cytokine that has been shown to be critical in colitis (38).”
BackgroundZhang, B., Liu, C., Qian, W., Han, Y., Li, X., & Deng, J. (2014) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s1399004714005227 · Cited by 38
Self-citationLiu, S., Zhang, Q., Chen, C., Ge, D., Qu, Y., Chen, R., Fan, Y.-M., Li, N., Tang, W. W., Zhang, W., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7296 · Cited by 42
“1 expressing human Act1 with HA tag were described previously [51] and were kindly provided by Dr.”
MethodSelf-citationDas, N. A., Carpenter, A. J., Yoshida, T., Kumar, S., Gautam, S., Mostany, R., Izadpanah, R., Kumar, A., Mummidi, S., Siebenlist, U. K., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.07.003 · Cited by 41
“, via recruitment of TAK1 (TGF-beta activated kinase 1) and the ubiquitinbinding proteins TAB1/2 (TGF-β Activated Kinase 1 and 2), resulting in IKK (IκB kinase) activation [27,28].”
BackgroundA Role of IL-17 in Rheumatoid Arthritis Patients Complicated With Atherosclerosis
Wang, J., He, L., Li, W., & Lv, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.828933 · Cited by 42
Immune diseases caused by mutations in kinases and components of the ubiquitin system
Cohen, P. (2014) · Nature Immunology · doi:10.1038/ni.2892 · Cited by 45
Human colon carcinogenesis is associated with increased interleukin-17-driven inflammatory responses
Xie, Z.-H., Qu, Y., Leng, Y., Sun, W., Ma, S., Wei, J., Hu, J.-G., & Zhang, X. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s79431 · Cited by 44
Crystal Structure of IL-17 Receptor B SEFIR Domain
Zhang, B., Liu, C., Qian, W., Han, Y., Li, X., & Deng, J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202922 · Cited by 38
“The cDNAs were synthesized, and real-time RTPCR assays were performed, as described previously (8).”
MethodSelf-citationKorn, A., Miller, D., Dong, L., Buckles, E. L., Wagner, B., & Ainsworth, D. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142622 · Cited by 38
Pyruvate kinase M2 mediates IL-17 signaling in keratinocytes driving psoriatic skin inflammation
Veras, F. P., Públio, G. A., de Melo, B. M. S., Prado, D. D. S., Norbiato, T., Cecílio, N. T., Hiroki, C. H., Damasceno, L. E. A., Jung, R., Toller-Kawahisa, J. E., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111897 · Cited by 38
Márquez, L., Shen, C., Cleynen, I., Hertogh, G. D., Steen, K. V., Machiels, K., Perrier, C., Ballet, V., Organe, S., Ferrante, M., et al. (2011) · Gut · doi:10.1136/gut.2011.240978 · Cited by 42
Erikson, J. M., Valente, A. J., Mummidi, S., Kandikattu, H. K., DeMarco, V. G., Bender, S. B., Fay, W. P., Siebenlist, U. K., & Chandrasekar, B. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.764522 · Cited by 39
“Its pathological role is also demonstrated in various autoimmune and inflammatory diseases (21, 22).”
BackgroundHuang, G., Wang, Y., Vogel, P., & Chi, H. (2015) · Science Signaling · doi:10.1126/scisignal.aaa2147 · Cited by 37
“Although studies have identified the pathogenic roles of IL-17Rs (10) and the IL-17R signaling adaptor molecule Act1 (11, 12), how TH17 cells participate in EAE pathogenesis and, in particular, how IL-17R signals are transduced by an intracellular signaling network in target cells remain unresolved.”
InfluentialCIKS/DDX3X Interaction Controls the Stability of the Zc3h12a mRNA Induced by IL-17
Somma, D., Mastrovito, P., Grieco, M., Lavorgna, A., Pignalosa, A., Formisano, L., Salzano, A. M., Scaloni, A., Pacifico, F., Siebenlist, U., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401589 · Cited by 36
TH17 cells promote CNS inflammation by sensing danger signals via Mincle
Zhang, Q., Liu, W., Wang, H., Zhou, H., Bulek, K., Chen, X., Zhang, C.-J., Zhao, J., Zhang, R., Liu, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30174-1 · Cited by 36
Self-citationThe Role of IL-17 in the Pathogenesis of Oral Squamous Cell Carcinoma
Ladjevac, N., Milovanović, M., Jevtović, A., Arsenijević, D., Stojanović, B., Stojanovic, M. D., Stojanović, B., Arsenijević, N., Arsenijević, A., & Milovanović, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129874 · Cited by 39
“In addition to the SEFIR domain, IL-17RA also contains a non-conserved region that extends ~100 residues beyond the SEFIR, termed a “SEFIR-Extension” (SEFEX) that is required for IL-17RA signaling [70,71], and with SEFIR comprises a single composite structural motif [72].”
BackgroundDiversity in post-transcriptional control of neutrophil chemoattractant cytokine gene expression
Hamilton, T., Novotny, M., Pavicic, P. J., Herjan, T., Hartupee, J., Sun, D., Zhao, C., & Datta, S. (2010) · Cytokine · doi:10.1016/j.cyto.2010.04.003 · Cited by 36
“the intracellular region and is able to interact with another SEFIR domain-containing adaptor protein termed Act1, which is necessary for most responses to IL-17 [75,76].”
Self-citationRadiation-Induced Dermatitis is Mediated by IL17-Expressing γδ T Cells
Liao, W., Hei, T. K., & Cheng, S. K. (2017) · Radiation Research · doi:10.1667/rr007cc.1 · Cited by 38
“IL17 receptors are universally expressed and IL17 pathway is essential for neutrophil recruitment through adaptor Act1 and transcription factor NF-jB (36).”
FYN–TRAF3IP2 induces NF-κB signaling-driven peripheral T-cell lymphoma
Moon, C. S., Reglero, C., Cortés, J. R., Quinn, S. A., Álvarez, S., Zhao, J., Lin, W.-H. W., Cooke, A. J., Abate, F., Soderquist, C. R., et al. (2021) · Nature Cancer · doi:10.1038/s43018-020-00161-w · Cited by 37
Metadata
- Authors
- Qian, Y., Liu, C., Hartupee, J., Altuntas, C. Z., Gulen, M. F., Jane-wit, D., Xiao, J., Lu, Y., Giltiay, N., Liu, J., Kordula, T., Zhang, Q.-W., Vallance, B., Swaidani, S., Aronica, M., Tuohy, V. K., Hamilton, T., & Li, X.
- Affiliations
- Cleveland Clinic (US)
- Case Western Reserve University (US)
- Virginia Commonwealth University (US)
- University of British Columbia (CA)
- Corresponding author
- Li, Xiaoxia
- ORCID
- Venue
- Nature Immunology
- Published
- 2007-02-04
- Volume
- 8
- Issue
- 3
- Pages
- 247-256
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2021674244
- Cited by
- 614
- References
- 45
- Citations by year
- 2026: 29 · 2025: 28 · 2024: 34 · 2023: 32 · 2022: 37 · 2021: 41 · 2020: 23 · 2019: 30 · 2018: 25 · 2017: 25 · 2016: 21 · 2015: 26 · 2014: 31 · 2013: 38 · 2012: 33
- FWCI
- 13.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI065470, AI 065470)
- National Institute of Neurological Disorders and Stroke (R01-NS071996)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- Act1, IL-17, IL-17 receptor signaling, TAK1, TRAF6, NF-κB activation, adaptor proteins, astrocytes, intestinal epithelial cells, autoimmune encephalomyelitis, DSS-induced colitis, inflammatory diseases, T helper cells
- MeSH terms
- Animals, Autoimmune Diseases, Colitis, Encephalomyelitis, Autoimmune, Experimental, Enzyme-Linked Immunosorbent Assay, Female, Fluorescent Antibody Technique, Gene Expression Regulation, HeLa Cells, Humans, Inflammation, T-Lymphocytes, Transfection, Signal Transduction, Autoimmunity, Gene Expression, CD40 Antigens, Adoptive Transfer, Reverse Transcriptase Polymerase Chain Reaction, Interleukin-17, Tumor Necrosis Factor Receptor-Associated Peptides and Proteins, Adaptor Proteins, Signal Transducing, Mice, B-Cell Activation Factor Receptor, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.